Philina Lee

Insider Reports History

Entity
Individual
Location
C/O Fusion Pharmaceuticals, Inc., 270 Longwood Road South, Hamilton, Bermuda
Signature
/s/ Melissa Masse, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Philina Lee:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Blueprint Medicines Corp CHIEF COMMERCIAL OFFICER Common Stock 34.7K $3.24M $93.19 Aug 5, 2024 Direct
Blueprint Medicines Corp CHIEF COMMERCIAL OFFICER Stock Option (Right to Buy) 0 Aug 5, 2024 Direct
Fusion Pharmaceuticals Inc. Director Stock Option (Right to Buy) 0 Jun 4, 2024 Direct

Insider Reports Filed by Philina Lee

Symbol Company Period Transactions Value $ Form Type Date Filed Role
BPMC Blueprint Medicines Corp Aug 5, 2024 15 -$1.08M 4 Aug 7, 2024 CHIEF COMMERCIAL OFFICER
FUSN Fusion Pharmaceuticals Inc. Jun 4, 2024 4 $0 4 Jun 4, 2024 Director
BPMC Blueprint Medicines Corp Mar 13, 2024 4 -$702K 4 Mar 15, 2024 CHIEF COMMERCIAL OFFICER
BPMC Blueprint Medicines Corp Mar 7, 2024 1 -$266K 4 Mar 11, 2024 CHIEF COMMERCIAL OFFICER
BPMC Blueprint Medicines Corp Mar 1, 2024 2 $0 4 Mar 6, 2024 CHIEF COMMERCIAL OFFICER
BPMC Blueprint Medicines Corp Dec 13, 2023 2 $488 4 Feb 14, 2024 CHIEF COMMERCIAL OFFICER
FUSN Fusion Pharmaceuticals Inc. Jun 14, 2023 1 $0 4 Jun 14, 2023 Director
BPMC Blueprint Medicines Corp Mar 6, 2023 2 -$76.6K 4 Mar 8, 2023 CHIEF COMMERCIAL OFFICER
BPMC Blueprint Medicines Corp Mar 1, 2023 2 $0 4 Mar 3, 2023 CHIEF COMMERCIAL OFFICER
FUSN Fusion Pharmaceuticals Inc. Jun 14, 2022 1 $0 4 Jun 22, 2022 Director
BPMC Blueprint Medicines Corp Apr 4, 2022 0 $0 3 Apr 14, 2022 Chief Commercial Officer
FUSN Fusion Pharmaceuticals Inc. Jun 4, 2021 1 $0 4 Jun 7, 2021 Director